showed pre-excitation and echocardiography revealed concentric hypertrophic cardiomyopathy with a septal and posterior wall thickness of 7-5 mm (normal 3-5-4-2 mm). There was no left or right ventricular outflow tract gradient. Treatment with digoxin and propanolol was introduced and there was no recurrence of the tachycardia.
Infantile cardiomyopathy has been described in several genetic metabolic diseases such as lysosomal storage, mitochondrial, amino acid, organic acid, and carnitine disorders.1 Recently, increasing interest has been focused on the manifestations of respiratory chain defects.2 3 In general they present either as isolated myopathy or as a multisystemic disorder with encephalomyopathy, nephropathy, hepatic involvement, and cardiomyopathy.46
We have attempted to define and explain the cardiomyopathy in respiratory chain disorders based on the observations in our patient as well as on the reports in the literature. Emphasis has been placed on the clinical course, pathophysiological mechanisms, and morphological abnormalities.
Methods
The case history of a 2 year old child with cardiomyopathy and encephalomyopathy due to a defect of the respiratory chain was compared with previous reports of patients with respiratory chain disorders and cardiac involvement. Since In disorders of the respiratory chain, however, cardiomyopathy presents as a concentric distribution of myocardial thickening with impaired diastolic and systolic function. The main histological findings are hypertrophic and swollen cardiocytes with reduced and disrupted myofibrils. Defects of electron transport and energy production, which play a vital part in myocardial energy metabolism may cause structural abnormalities of mitochondria. 10 37 It has been suggested that mitochondrial proliferation is an attempt by the cardiac muscle cell to compensate for deficient energy production. The increased number of mitochondria leads to cellular swelling and myocardial hypertrophy. 16 Decreased systolic function may therefore be the result of reduced myofibrils and defective mitochondrial function.
During the last decade mutations and deletions of the mitochondrial and nuclear genome have been established as the basic defect in many of the disorders of the respiratory chain. 38 The involvement of mitochondrial DNA explains many of the special features of disorders of oxidative phosphoryla- 
